Welcome to Coulter Partners Global (English)

10 December 2024

Top global hires for large-cap, mid-cap and public companies H2-2024

Recent top global hires for large-cap, mid-cap, and public companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

CEO/ C-suite/ Board

Function Focus area Location
CEO Medtech (publicly listed) APAC
CEO Life science tools (publicly listed) Nordics
President Life Sciences Specialty chemicals (large-cap) UK & Ireland
Chief Financial Officer Biotech (publicly listed) US
Chief Financial Officer Biopharma/ drug delivery (publicly listed) UK & Ireland
Chief of Staff Biopharma (publicly listed) Europe
Chair Mental health pharma (publicly listed) US/ UK

Commercial / Functional / Strategic Leadership

Function Focus area Location
VP, Artificial Intelligence Drug discovery (publicly listed) UK & Ireland
Head of Corporate Business Development Pharma (mid-cap) Europe
Country Launch Distribution Head Specialty pharma (mid-cap) Europe
Head of Human Resources Europe Pharma (publicly listed) US
Country Head of Market Access Platform technology (publicly listed) Europe
Director, Innovation and New Technologies Biopharma (publicly listed) UK & Ireland
Country Senior Director, Pricing and Market Access Biotech (large-cap) US/ UK

R&D/ Medical/ Technical

Function Focus area Location
EVP/ Head of R&D/ Chief Medical Officer Diversified pharma (publicly listed) US
VP, Inflammation Rheumatology Pharma (large-cap) US
VP, Technical Operations Drug technologies (mid-cap) Europe
VP, Head of Obesity Development Pharma (large-cap) US
VP, Global Medical Affairs, Oncology Pharma (large-cap) US
Head of Quality Management Biopharma (mid-cap) Europe
Country Director, Medical Affairs Pharma (mid-cap) Europe
Director, Clinical Research Specialty pharma (mid-cap) Europe
Medical Director Biopharma (publicly listed) US
Quality Affairs Director Animal health (large-cap) Europe

Related

A new version of Coulter Partners is available.